Francine Welle

Doctor of Osteopathic Medicine,  Cleveland Clinic 

Location: Germany

Consulting Services

Legal Support Sales and Marketing IT-Web-Mobile Technology Career Advice and Mentoring

Areas Of Interest

Protea Plants Transcription Factor, Pou4f2 Nucleus of Darkschewitsch Urispas Acetate, Chlorhexidine Guanosine 3' Diphosphate 5' Triphosphate Infectious Pregnancy Complications Olive Tree Streptococcus pneumoniae Meningitis Triphosphopyridine Nucleotide-Nitrate Reductase Meningitis, Streptococcus pneumoniae Poria cocos Enteropathy, Exudative t-Haplotype, Mouse Nodes, AV Caroli Disease Uroporphyrinogen III Synthetase Secondary Olfactory Cortex MDL 17,043 Arterial Lines Uchida Method Radioactive Tracers Voyeurisms I Cyanopindolol Heparan Sulfate Bacteroides gingivalis Hypersomnias, Idiopathic Vessel, Retinal SM 13496 Desoxycorticosterone-21-acetate p38alpha Mitogen Activated Protein Kinase Culture Type VIIs, Mucopolysaccharidosis Bone Sialoprotein 1 Pericentriolar Region Needle Biopsies, Fine Vesicles, COP-Coated Role, Sick Symptom Cluster

Professional Narrative

Dr. Francine Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Amgen 2003
Medical Writer, Harvard Med 2000

Education

Master of Science in physician assistant, Harvard Medical School 1997
Master of Science in physician assistant, Harvard Medical School 1996

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :